Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-11-07

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA has approved a supplemental application for metformin hydrochloride filed by Oceanside Pharmaceuticals. The submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)